针对MARCO与抗CTLA-4结合,导致通过巨细胞重编程增强黑色素瘤回归和免疫细胞透
Hidenori Takahashi1, Patricio Perez-Villarroel1, Rana Falahat1
1Immunology, Moffitt Cancer Center, Tampa, Florida, USA.
Journal for immunotherapy of cancer
|March 13, 2025
概括
用ED31抗体准具有原结构的巨细胞受体 (MARCO) 通过重新编程免疫抑制巨细胞来增强抗CTLA-4癌症免疫疗法. 这种策略通过增加免疫细胞透到瘤微环境中来提高抗瘤功效.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 癌症免疫疗法癌症免疫疗法
背景情况:
- 免疫检查点抑制剂 (ICI) 在癌症免疫治疗中至关重要,但它们的有效性可能受到免疫抑制瘤微环境 (TME) 的限制.
- 抑制性巨细胞 (Mφ) 在TME中很丰富,与预后不佳有关,但选择性的Mφ耗尽在临床试验中失败了.
- 具有原结构的巨细胞受体 (MARCO),Mφ上的拾取受体,在瘤细胞吸收后在树突细胞 (DC) 中升级,但其TME意义尚不清楚.
研究的目的:
- 通过使用抗小鼠MARCO抗体 (ED31) 与ICI结合,研究针对MARCO的治疗潜力.
- 阐明MARCO抑制影响瘤微环境和免疫细胞透的机制.
- 评估巨细胞在观察到的治疗效果中的作用.
主要方法:
- 在小鼠瘤模型 (B16F10,Pan02) 中,抗MARCO抗体ED31与抗CTLA-4或抗PD-1结合测试.
- 使用流式细胞计,体内Mφ耗尽和体内功能测试来分析TME和Mφ贡献.
- 用多重测试量化化莫金产量,以了解TME重编程.
主要成果:
- ED31与抗CTLA-4相结合,但不是抗PD-1,显著增强了抗瘤功效.
- 组合疗法导致免疫细胞透的增加,包括成熟的DC招募,由Mφ介导的M1模式化学激素产生.
- Mφ耗尽取消了增强的免疫透,化学激素生产和组合治疗的抗瘤作用.
结论:
- 向MARCO代表了增强抗CTLA-4免疫疗法的可行策略.
- 该机制涉及对免疫抑制Mφ进行重新编程,使其转向类似M1的表型,而不是耗尽.
- 马可作为TME中的一个额外的检查点,可以针对改善癌症免疫治疗结果.
更多相关视频
07:44Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports
Published on: November 28, 2019
7.4K
07:55Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer
Published on: January 17, 2025
553
相关概念视频
01:27Tumor Immunotherapy
457
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
457
02:17The Tumor Microenvironment
6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K